The identification of a putative gene controlling the CD8+ T-lymphocyte numbers may be of great relevance not only in the management of hemochromatosis but also in other clinical situations where iron and lymphocytes may be important pathologic co-factors, such as in cancer and infection. Here, CD8A is linked to hemochromatosis.